SK286903B6 - Prípravok obsahujúci alkoxy substituované benzimidazolové zlúčeniny, farmaceutická formulácia s jeho obsahom, spôsob jej prípravy a použitie - Google Patents

Prípravok obsahujúci alkoxy substituované benzimidazolové zlúčeniny, farmaceutická formulácia s jeho obsahom, spôsob jej prípravy a použitie Download PDF

Info

Publication number
SK286903B6
SK286903B6 SK281-2002A SK2812002A SK286903B6 SK 286903 B6 SK286903 B6 SK 286903B6 SK 2812002 A SK2812002 A SK 2812002A SK 286903 B6 SK286903 B6 SK 286903B6
Authority
SK
Slovakia
Prior art keywords
methoxy
methyl
pyridinyl
dimethyl
sulfinyl
Prior art date
Application number
SK281-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK2812002A3 (en
Inventor
Robert R. Whittle
Frederick D. Sancilio
Grayson Walker Stowell
Douglas John Jenkins
Linda Whittall
Glenn Alan Meyer
Steven A. Fontana
Original Assignee
Aaipharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/519,976 external-priority patent/US6262085B1/en
Application filed by Aaipharma Inc. filed Critical Aaipharma Inc.
Publication of SK2812002A3 publication Critical patent/SK2812002A3/sk
Publication of SK286903B6 publication Critical patent/SK286903B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK281-2002A 1999-08-26 2000-08-25 Prípravok obsahujúci alkoxy substituované benzimidazolové zlúčeniny, farmaceutická formulácia s jeho obsahom, spôsob jej prípravy a použitie SK286903B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15087899P 1999-08-26 1999-08-26
US09/519,976 US6262085B1 (en) 1999-08-26 2000-03-07 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
PCT/US2000/023363 WO2001014367A1 (en) 1999-08-26 2000-08-25 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Publications (2)

Publication Number Publication Date
SK2812002A3 SK2812002A3 (en) 2002-07-02
SK286903B6 true SK286903B6 (sk) 2009-07-06

Family

ID=26848119

Family Applications (1)

Application Number Title Priority Date Filing Date
SK281-2002A SK286903B6 (sk) 1999-08-26 2000-08-25 Prípravok obsahujúci alkoxy substituované benzimidazolové zlúčeniny, farmaceutická formulácia s jeho obsahom, spôsob jej prípravy a použitie

Country Status (16)

Country Link
EP (1) EP1206466B1 (ru)
JP (1) JP4312405B2 (ru)
KR (1) KR100712039B1 (ru)
CN (2) CN1183127C (ru)
AT (1) ATE306483T1 (ru)
AU (2) AU777667B2 (ru)
BR (1) BR0014145A (ru)
CA (1) CA2382867A1 (ru)
DE (1) DE60023154T2 (ru)
HR (1) HRP20020174A2 (ru)
MX (1) MXPA02002007A (ru)
NO (1) NO326849B1 (ru)
RO (1) RO122491B1 (ru)
RU (1) RU2263673C2 (ru)
SI (1) SI20974A (ru)
SK (1) SK286903B6 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
KR20130038949A (ko) * 2004-06-24 2013-04-18 아스트라제네카 아베 에소메프라졸 나트륨염의 제조에서 사용하기 위한 결정 변형의 제조를 위한 신규한 방법
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
CN103524491A (zh) * 2013-10-16 2014-01-22 江南大学 埃索美拉唑镁盐四水合物的三种晶型及其制备方法
CN114558004B (zh) * 2022-03-29 2023-08-11 奎马特里克斯有限公司 Qtx125药物制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds

Also Published As

Publication number Publication date
DE60023154D1 (de) 2006-02-23
KR20020035861A (ko) 2002-05-15
RO122491B1 (ro) 2009-07-30
CN1636564A (zh) 2005-07-13
BR0014145A (pt) 2002-05-14
MXPA02002007A (es) 2003-08-20
RU2263673C2 (ru) 2005-11-10
JP2003507475A (ja) 2003-02-25
AU2005200203B2 (en) 2008-01-10
AU2005200203A1 (en) 2005-02-10
CA2382867A1 (en) 2001-03-01
EP1206466B1 (en) 2005-10-12
CN1183127C (zh) 2005-01-05
ATE306483T1 (de) 2005-10-15
NO20020914D0 (no) 2002-02-25
AU777667B2 (en) 2004-10-28
EP1206466A1 (en) 2002-05-22
NO20020914L (no) 2002-04-26
CN1384831A (zh) 2002-12-11
NO326849B1 (no) 2009-03-02
DE60023154T2 (de) 2006-06-22
SI20974A (sl) 2003-02-28
AU7073700A (en) 2001-03-19
SK2812002A3 (en) 2002-07-02
KR100712039B1 (ko) 2007-04-27
HRP20020174A2 (en) 2005-12-31
JP4312405B2 (ja) 2009-08-12

Similar Documents

Publication Publication Date Title
US6369087B1 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) Dry blend pharmaceutical formulations
WO2001014367A1 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) Pharmaceutical unit dosage form
US20100286400A1 (en) Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
US8222422B2 (en) Crystal of benzimidazole compound
US6326384B1 (en) Dry blend pharmaceutical unit dosage form
US6312723B1 (en) Pharmaceutical unit dosage form
AU2005200203B2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) Pharmaceutical formulations
US6312712B1 (en) Method of improving bioavailability
EP1889841A1 (en) Crystal of salt of benzimidazole compound
EP1595879A2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100825